TrialX
Image

Isbah: SIB Accelerated Hyperfractionated RT for High-Proliferation NSCLC (HP-SIB-AHFRT)

Participate in a trial for new lung cancer radiation therapy.

Recruiting
All
  • Simplified description (AI rewritten)
  • Technical description (Original)

Study Purpose: We are conducting a research study to learn more about a special type of radiation therapy for people with high-proliferation non-small cell lung cancer (NSCLC). This type of cancer grows quickly, and NSCLC is a common form of lung cancer. The study aims to check the safety and how well this treatment works in improving the patients' health.

Who Can Join? To join, you must be 18 years or older and have been diagnosed with high-proliferation NSCLC. A team of doctors should have planned for you to receive chest radiation therapy. If your lung cancer is of a small cell type or you have severe heart disease, you might not be eligible. Pregnant women and those in other clinical trials cannot join.

  • The study will last for a specific period as determined by your doctor.
  • You will need to visit the study center various times for treatment and check-ups.
  • There is no cost for participating, but you should discuss any potential risks with your doctor.

If you are interested in learning more, please talk to your healthcare provider.

Study details
    Non-Small Cell Lung Cancer

NCT07823855

26 October 2026

Contact a study center
Step 1

Check your eligibility to see if you may qualify for this clinical study

1. Answer a 2-minute questionnaire.

A first step as you consider this study is to answer a 2-minute online questionnaire about your health and medical history. You will also be asked to provide your zip code, which may be used by TrialX, and our partners working on this study to help improve the study recruitment process. If your answers show the study might be a good fit for you, you may choose to have your contact information shared with a TrialX Clinical Trial Contact Center Navigator.

2. Speak with a study representative

If you’re interested, a TrialX Clinical Trial Contact Center Navigator will call you and do a more detailed review of the study and your medical history to see if you may be able to participate and be referred to a study clinic.


Preview complete

The prescreener preview is complete. You may now close the preview.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.